Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 24;26(1):263.
doi: 10.1186/s12859-025-06280-4.

VaMiAnalyzer: an open source, Python-based application for analysis of 3D in vitro vasculogenic mimicry assays

Affiliations

VaMiAnalyzer: an open source, Python-based application for analysis of 3D in vitro vasculogenic mimicry assays

Stephen P G Moore et al. BMC Bioinformatics. .

Abstract

Background: Vasculogenic mimicry (VM) is the phenomenon whereby non-vascular tumor cells develop vascular-like structures. VM is linked to more aggressive tumor phenotypes including higher rates of metastasis and invasion and is potentially resistant to anti-angiogenic cancer therapies. VM is investigated in vitro using 3D assays with microscopy images capturing the resulting VM structures, including loops, branch points, and tubes. The standard method to quantify endpoint data is to count various structural features manually, which is time-consuming and open to bias. At present, no software solutions have been developed to specifically address the analysis and quantification of VM structures.

Results: To address this limitation, we developed an open source, Python-based application, VaMiAnalyzer, allowing straightforward quantification of several VM structural features. The application follows a two-step approach that optionally corrects and enhances the raw input images and then analyzes and quantifies the VM features.

Conclusions: VaMiAnalyzer is stand-alone software that allows automated measurement of VM structural features from phase-contrast microscopy images. It produces results that are strongly consistent with manual counts but in a significantly shorter time, allowing quick, non-biased analysis of VM from microscopy images.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Overview of VaMiAnalyzer two-step image analysis process. Raw images are analyzed for VM structures either directly or following background and shading correction. Representative images corresponding to each step in the workflow are shown below their respective stages in the analysis pipeline. (1) Raw image input. (2) Corrected image after background and shading correction. (3) Analyzed image featuring tubes (white lines), branch points (yellow dots), and loop counts (orange numbers)
Fig. 2
Fig. 2
Comparison of output from VaMiAnalyzer, WimTube, and Angiogenesis Analyzer on a representative VM image. A VaMiAnalyzer output, featuring tubes (white lines), branch points (yellow dots), and loop counts (orange numbers). B WimTube, featuring tubes (red lines), branch points (white dots), loop counts (yellow numbers), and cell covered region (blue overlay). C Angiogenesis Analyzer, featuring tubes (green and blue lines), branch points (purple dots), and loops (area completely enclosed by yellow lines). The white arrows added post analysis, in C indicate loop examples in areas of confluent cell growth
Fig. 3
Fig. 3
Comparison of VM analysis by VaMiAnalyzer, manual counting, and the WimTube tube formation image analysis program. Counts of loops, branches, and tubes did not differ significantly between the VaMiAnalyzer or manual counting of structures using 40 images (p > 0.05). The WinTube program results were significantly different from the other two groups for all three structural features ( *** p < 0.05)

Update of

References

    1. Tonini T, Rossi F, Claudio PP. Molecular basis of angiogenesis and cancer. Oncogene. 2003;22(42):6549–56. - PubMed
    1. Hendrix MJ, Seftor EA, Seftor RE, Chao JT, Chien DS, Chu YW. Tumor cell vascular mimicry: novel targeting opportunity in melanoma. Pharmacol Ther. 2016;159:83–92. - PMC - PubMed
    1. Folberg R, Hendrix MJ, Maniotis AJ. Vasculogenic mimicry and tumor angiogenesis. Am J Pathol. 2000;156(2):361–81. - PMC - PubMed
    1. Kirschmann DA, Seftor EA, Hardy KM, Seftor RE, Hendrix MJ. Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications. Clin Cancer Res. 2012;18(10):2726–32. - PMC - PubMed
    1. Cao Z, Bao M, Miele L, Sarkar FH, Wang Z, Zhou Q. Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: a systemic review and meta-analysis. Eur J Cancer. 2013;49(18):3914–23. - PubMed

LinkOut - more resources